Ever imagine what the impact of misidentifying the correct mutation could be on cancer or missing critical information in your research? What would the impact of missing an already identified variant be on your research? These questions are best left unanswered by choosing to work with only the best and most comprehensive database for human cancer mutations.
With over 23 million genomic variants, COSMIC is the world’s largest expert-curated somatic mutation database. Trusted by over 50,000 users, it is integral to any clinical assessment of somatic variants. Integrating COSMIC into your NGS pipeline accelerates cancer sample analysis by rapidly prioritizing cancer driver mutations, distinguishing VUSes, and determining if an alteration is common or rare in the cancer type of interest.
Empower your research and diagnosis with the world’s largest database of human cancer mutations
with well over 50,000 users and in excess of 10,000 citations
COSMIC provides genome wide annotation with over 23 million genomic variants across 6,800 precise cancer types.
COSMIC includes over 1.5 million manually curated human samples, including 39,000 genomes with unbiased, genome-level profiling of diseases with objective frequency data.
Every four months, COSMIC content and features are updated to ensure you remain informed on the latest findings.
As NGS panels increase in depth-of-gene coverage and more treatment options become available, labs need access to current data and relevant evidence to support actionable decision-making.
However, every year you don’t renew your COSMIC license, your lab is not accessing the latest, high-quality information needed to drive accurate and actionable point-of-care decisions. COSMIC is constantly updated with the latest information on cancer mutations.
The sixth release of Actionability, the newest product in the COSMIC suite, is now available. Actionability is a vital tool for anyone working in precision oncology, offering expert-curated information on the availability and development of drugs targeting somatic mutations in cancer, as well as case studies, clinical trials, and regulatory body data critical to improving precision oncology decision-making.
Identifying and studying actionable variants is of great interest to many investigators.
Watch this webinar recording, where COSMIC, HGMD and QIAGEN Knowledge Base is introduced for annotation and investigation of both somatic and germline variants.
COSMIC has been fueling cancer research for the past 15 years. From its humble beginnings, see how this knowledge base plays its part in the fight against cancer and making a difference in patient care.
Clinical decision support software integrated with professional variant interpretation services that enables rapid, evidence-based reporting for NGS oncology testing at scale.
Reimagine your clinical interpretation with same day, expert variant classification services tailored to your oncology panel
Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities